EMPRISE
Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care. Click here to find out more information.
Search
COVID-19 Once a nurse always a nurse
Colleagues Anne Hunstad and Maarten van Helvoirt, both educated nurses, support the health care workers during the COVID-19 pandemic. Learn more.
Professor Gregory Lip introduces the GLORIA™-AF Registry
In this video, Prof. Gregory Lip introduces the GLORIA™-AF Registry Program. Click here to watch the video and to learn more about the program.
COVID-19 RCV thank you
A big thank you to all doctors, all nurses and all others working in the healthcare sector from the employees of BI Regional Centre Vienna. Read more here!
How do I treat mild to moderate renal impairment with Pradaxa®
Watch experts discuss how to calculate the renal function of the patients and the appropriate use of Pradaxa® in patients. Click here to watch the video.
Harold Heart and Dorothy Diabetes
People with type 2 diabetes are up to four times more likely to develop cardiovascular disease than people without diabetes. Click here to learn more.
COVID-19 Mentally strengthened through the Corona crisis
Our individual employee consultation offers employees several support options to manage the pandemic with strengthened mental health. Learn more.
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.
Sustainable Development
Discover our 'Sustainable Development - For Generations' journey. The journey not only involves the current generation but future ones to come.
Patient voices Ulrichs story
‘Telling My Story’ is a video series featuring stories from patients from across the world with AF, DVT and PE. Click here to hear Ulrich's story.
Patient voices Eves story
‘Telling My Story’ is a video series featuring stories from patients from across the world with AF, DVT and PE. Click here to hear Eve's story.
Patient voices Augustos story
Hear from patients and families on how atrial fibrillation (AF), deep vein thrombosis (DVT) and pulmonary embolism (PE) have affected their lives.
Our Contribution
Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come. Click here to find out more.
Diabetes
About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. Learn more here.
PCI with stenting animation
Atrial fibrillation (AF) is the most common cardiac rhythm disorder worldwide. Click here for more information on Stroke Prevention in atrial fibrillation.
1988-2015
Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.
Shanghai
Shanghai serves as an important hub for all of the company’s three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.
Poultry
We are proud to play a critical role in feeding the world with safe, affordable, abundant and sustainable quality poultry meat and eggs. Learn more here.
Pets
We continuously innovate and expand our pet health solutions to address unmet needs. Click here to learn more about our work on pet health here.
COVID-19 Jordan medicine donations
Boehringer Ingelheim donates medicines in Jordan to support patients with chronic conditions. Click here to find out more about this support.
Supporting Fundappas
Fundappas is the first school of guide and assistance dogs in Uruguay. We support Fundappas to improve the quality of life of dogs and people. Learn more.
Dr. V. Mohan Releases 9-point Action for People with Diabetes
Dr V. Mohan has released a 9-point action plan to ensure health for people with diabetes. Click here to read the press release and find out more.
Commits to Thoracic Society’s COVID-19 Fund
Boehringer Ingelheim is committing USD 500,000 (around EUR 458,000) to the American Thoracic Society (ATS) and its COVID-19 Crisis Fund. Learn more here.
Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
Obesity osteoarthritis in pets a blind spot
Body weight is just one indicator among many when it comes to a pet’s health status, but there are some diseases associated with it. Learn more here.